Full Text
The Full Text of this article is available as a PDF (285.0 KB).
References
- 1.Roffman D.S. Special concerns of digitalis use in elderly patients. Geriatrics. 1984;39(6):97–98. [PubMed] [Google Scholar]
- 2.Professional Practice in Toxicology. A Review. (1994) CME 3rd edition. University of Cincinnati (Sponsored by the American Association of Clinical Chemistry and the National Academy for Clinical Chemistry) p. 149–170.
- 3.Hager W.D., Fenster P., Mayersohn M. Digoxin-Quinidine interaction: Pharmacokinetic Evaluation. New Engl. J. Med. 1979;300(22):1238–1241. doi: 10.1056/NEJM197905313002202. [DOI] [PubMed] [Google Scholar]
- 4.Ochs H.R., Bodem G., Greenbalt D.S. Impairment of Digoxin Clearance by Coadministration of Quinidine. J. Clin. Pharmacol. 1981;21(10):396–400. doi: 10.1002/j.1552-4604.1981.tb01739.x. [DOI] [PubMed] [Google Scholar]
- 5.Njinimbam C.C.G., Ryder K.W., Glick M.R., Glick S.J., Whang R. Identification and treatment of Hypomagnesis and Hypokalemia in patients receiving Digoxin. Clinical Chemistry. 1990;36(3):575–576. [PubMed] [Google Scholar]
- 6.Harmon C.E., Pontanova J.P. Drug-induced lupus: Clinical and serological studies—Review. Clinics in Rheum. Dis. 1982;8(1):121–135. [PubMed] [Google Scholar]
- 7.Mason J.W. Amiodarone. New Engl. J. Med. 1987;316(8):455–466. doi: 10.1056/NEJM198702193160807. [DOI] [PubMed] [Google Scholar]
- 8.Podrid J.P. Aggravation of Arrhythmia by Antiarrhythmic Drugs. In: Messerli F.H., editor. Cardiovascular Drug Therapy. Philadelphia, USA: W.B. Saunders Co.; 1990. pp. 1152–1192. [Google Scholar]